• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素样肽-1与下丘脑对饱腹感的调节:来自人类和动物研究的认知与神经学见解

Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.

作者信息

Park Joon Seok, Kim Kyu Sik, Choi Hyung Jin

机构信息

Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.

Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Diabetes Metab J. 2025 May;49(3):333-347. doi: 10.4093/dmj.2025.0106. Epub 2025 May 1.

DOI:10.4093/dmj.2025.0106
PMID:40367985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12086555/
Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as blockbuster drugs for treating metabolic diseases. Glucagon-like peptide-1 (GLP-1) plays a pivotal role in glucose homeostasis by enhancing insulin secretion, suppressing glucagon release, delaying gastric emptying, and acting on the central nervous system to regulate satiation and satiety. This review summarizes the discovery of GLP-1 and the development of GLP-1RAs, with a particular focus on their central mechanisms of action. Human neuroimaging studies demonstrate that GLP-1RAs influence brain activity during food cognition, supporting a role in pre-ingestive satiation. Animal studies on hypothalamic feed-forward regulation of hunger suggest that cognitive hypothalamic mechanisms may also contribute to satiation control. We highlight the brain mechanisms of GLP-1RA-induced satiation and satiety, including cognitive impacts, with an emphasis on animal studies of hypothalamic glucagon-like peptide-1 receptor (GLP-1R) and GLP-1R-expressing neurons. Actions in non-hypothalamic regions are also discussed. Additionally, we review emerging combination drugs and oral GLP-1RA formulations aimed at improving efficacy and patient adherence. In conclusion, the dorsomedial hypothalamus (DMH)-a key GLP-1RA target-mediates pre-ingestive cognitive satiation, while other hypothalamic GLP-1R neurons regulate diverse aspects of feeding behavior, offering potential therapeutic targets for obesity treatment.

摘要

胰高血糖素样肽-1受体激动剂(GLP-1RAs)已成为治疗代谢性疾病的重磅药物。胰高血糖素样肽-1(GLP-1)通过增强胰岛素分泌、抑制胰高血糖素释放、延缓胃排空以及作用于中枢神经系统来调节饱腹感,在葡萄糖稳态中发挥关键作用。本综述总结了GLP-1的发现及GLP-1RAs的研发,尤其关注它们的中枢作用机制。人体神经影像学研究表明,GLP-1RAs在食物认知过程中会影响大脑活动,支持其在进食前饱腹感方面的作用。关于下丘脑对饥饿的前馈调节的动物研究表明,认知性下丘脑机制也可能有助于饱腹感控制。我们重点介绍了GLP-1RA诱导饱腹感和饱足感的脑机制,包括认知影响,特别强调了对下丘脑胰高血糖素样肽-1受体(GLP-1R)和表达GLP-1R的神经元的动物研究。还讨论了其在非下丘脑区域的作用。此外,我们综述了旨在提高疗效和患者依从性的新型联合药物及口服GLP-1RA制剂。总之,下丘脑背内侧核(DMH)——GLP-1RA的关键靶点——介导进食前的认知性饱腹感,而下丘脑其他表达GLP-1R的神经元则调节进食行为的多个方面,为肥胖治疗提供了潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a1/12086555/f9fafb8be924/dmj-2025-0106f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a1/12086555/08fa50f5b67a/dmj-2025-0106f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a1/12086555/e43363aa9367/dmj-2025-0106f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a1/12086555/f9fafb8be924/dmj-2025-0106f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a1/12086555/08fa50f5b67a/dmj-2025-0106f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a1/12086555/e43363aa9367/dmj-2025-0106f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a1/12086555/f9fafb8be924/dmj-2025-0106f3.jpg

相似文献

1
Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.胰高血糖素样肽-1与下丘脑对饱腹感的调节:来自人类和动物研究的认知与神经学见解
Diabetes Metab J. 2025 May;49(3):333-347. doi: 10.4093/dmj.2025.0106. Epub 2025 May 1.
2
GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans.GLP-1 通过小鼠和人类的下丘脑回路增加摄食前饱腹感。
Science. 2024 Jul 26;385(6707):438-446. doi: 10.1126/science.adj2537. Epub 2024 Jun 27.
3
Intestinal glucagon-like peptide-1 effects on food intake: Physiological relevance and emerging mechanisms.肠道胰高血糖素样肽-1 对摄食的影响:生理相关性和新出现的机制。
Peptides. 2020 Sep;131:170342. doi: 10.1016/j.peptides.2020.170342. Epub 2020 Jun 6.
4
Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism.位于下丘脑背内侧核的葡萄糖感应胰高血糖素样肽-1 受体神经元调节葡萄糖代谢。
Sci Adv. 2022 Jun 10;8(23):eabn5345. doi: 10.1126/sciadv.abn5345. Epub 2022 Jun 8.
5
Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.内源性后脑胰高血糖素样肽-1受体激活通过介导胃饱足信号传导来调控食物摄入量。
Endocrinology. 2009 Jun;150(6):2654-9. doi: 10.1210/en.2008-1479. Epub 2009 Mar 5.
6
The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.下丘脑胰高血糖素样肽-1受体对小鼠能量平衡和葡萄糖稳态的调节是充分但非必要的。
Diabetes. 2017 Feb;66(2):372-384. doi: 10.2337/db16-1102. Epub 2016 Dec 1.
7
GLP-1 modulates the supramammillary nucleus-lateral hypothalamic neurocircuit to control ingestive and motivated behavior in a sex divergent manner.GLP-1 以性别差异的方式调节乳头上核-外侧下丘脑神经回路来控制摄食和动机行为。
Mol Metab. 2019 Feb;20:178-193. doi: 10.1016/j.molmet.2018.11.005. Epub 2018 Nov 27.
8
The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.胰高血糖素样肽-1功能障碍在肥胖中的作用及潜在治疗意义。
Diabetes Obes Metab. 2014 Jan;16(1):9-21. doi: 10.1111/dom.12119. Epub 2013 May 26.
9
Peptide-YY/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries.肽 YY/胰高血糖素样肽-1 联合治疗肥胖型糖尿病小鼠可改善胰岛素敏感性,与恢复的胰腺β细胞功能以及离散的下丘脑和脑干神经元回路的协同激活有关。
Mol Metab. 2022 Jan;55:101392. doi: 10.1016/j.molmet.2021.101392. Epub 2021 Nov 12.
10
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.胰高血糖素样肽-1 受体激动剂和二肽基肽酶-4 抑制剂的心血管作用和临床结局。
Circulation. 2017 Aug 29;136(9):849-870. doi: 10.1161/CIRCULATIONAHA.117.028136.

引用本文的文献

1
Hijacked Brain in Modern Obesity: Cue, Habit, Addiction, Emotion, and Restraint as Targets for Personalized Digital Therapy and Electroceuticals.现代肥胖症中被劫持的大脑:线索、习惯、成瘾、情绪及克制作为个性化数字疗法和电子药物的靶点
J Obes Metab Syndr. 2025 Jul 30;34(3):196-212. doi: 10.7570/jomes25053. Epub 2025 Jul 24.

本文引用的文献

1
A comprehensive spatio-cellular map of the human hypothalamus.人类下丘脑的综合空间细胞图谱。
Nature. 2025 Mar;639(8055):708-716. doi: 10.1038/s41586-024-08504-8. Epub 2025 Feb 5.
2
Mapping the effectiveness and risks of GLP-1 receptor agonists.绘制胰高血糖素样肽-1受体激动剂的有效性和风险图谱。
Nat Med. 2025 Mar;31(3):951-962. doi: 10.1038/s41591-024-03412-w. Epub 2025 Jan 20.
3
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial).
司美格鲁肽能否减少丹麦酒精使用障碍合并肥胖患者的酒精摄入量?一项随机、双盲、安慰剂对照临床试验的试验方案(SEMACLO试验)。
BMJ Open. 2025 Jan 8;15(1):e086454. doi: 10.1136/bmjopen-2024-086454.
4
Predicting responsiveness to GLP-1 pathway drugs using real-world data.利用真实世界数据预测对胰高血糖素样肽-1(GLP-1)通路药物的反应性。
BMC Endocr Disord. 2024 Dec 18;24(1):269. doi: 10.1186/s12902-024-01798-9.
5
Leptin receptor neurons in the dorsomedial hypothalamus require distinct neuronal subsets for thermogenesis and weight loss.下丘脑背内侧的瘦素受体神经元在产热和体重减轻方面需要不同的神经元亚群。
Metabolism. 2025 Feb;163:156100. doi: 10.1016/j.metabol.2024.156100. Epub 2024 Dec 12.
6
coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist.共表达神经元通过胰高血糖素样肽-1/瘦素双重激动剂调节食物摄入和体重的抑制。
Sci Transl Med. 2024 Dec 4;16(776):eadk4908. doi: 10.1126/scitranslmed.adk4908.
7
Molecular connectomics reveals a glucagon-like peptide 1-sensitive neural circuit for satiety.分子连接组学揭示了一种对胰高血糖素样肽1敏感的饱腹感神经回路。
Nat Metab. 2024 Dec;6(12):2354-2373. doi: 10.1038/s42255-024-01168-8. Epub 2024 Dec 3.
8
Activation of the HPA Axis Does Not Explain Nonresponsiveness to GLP-1R Agonist Treatment in Individuals With Type 2 Diabetes.HPA轴的激活并不能解释2型糖尿病患者对GLP-1受体激动剂治疗无反应的原因。
Diabetes. 2025 Feb 1;74(2):212-222. doi: 10.2337/db24-0463.
9
A normative framework dissociates need and motivation in hypothalamic neurons.一个规范框架将下丘脑神经元中的需求和动机分离开来。
Sci Adv. 2024 Nov 8;10(45):eado1820. doi: 10.1126/sciadv.ado1820. Epub 2024 Nov 6.
10
GLP-1R-positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice.外侧隔核中的 GLP-1R 阳性神经元介导利拉鲁肽在小鼠中的摄食抑制和体重降低作用。
J Clin Invest. 2024 Sep 3;134(17):e178239. doi: 10.1172/JCI178239.